NEWS
Bionor Immuno and Bachem sign agreement on supply of active ingredients and finished dosage forms for Bionor Immuno's vaccine development projects
28. Jan 2009
Bachem and Bionor Immuno announced today the conclusion of an agreement for the development and supply of active pharmaceutical ingredients and finished dosage forms for Bionor Immuno's peptide-based vaccine development projects.